Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
WST

WST - West Pharmaceutical Services Inc Stock Price, Fair Value and News

$235.88-4.65 (-1.93%)
Market Closed

42/100

WST

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

42/100

WST

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$197.37

Target 3M

$226.25

Target 6M

$216.07

WST Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

WST Price Action

Last 7 days

-7.6%

Last 30 days

-14.4%

Last 90 days

-15.3%

Trailing 12 Months

-31.3%

WST RSI Chart

WST Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

WST Valuation

Market Cap

17.0B

Price/Earnings (Trailing)

34.51

Price/Sales (Trailing)

5.62

EV/EBITDA

21.59

Price/Free Cashflow

44.76

WST Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$197.37

Target 3M

$226.25

Target 6M

$216.07

WST Fundamentals

WST Revenue

Revenue (TTM)

3.0B

Rev. Growth (Yr)

7.73%

Rev. Growth (Qtr)

4.97%

WST Earnings

Earnings (TTM)

491.7M

Earnings Growth (Yr)

2.94%

Earnings Growth (Qtr)

6.22%

WST Profitability

EBT Margin

20.02%

Return on Equity

16.11%

Return on Assets

11.98%

Free Cashflow Yield

2.23%

WST Investor Care

Dividend Yield

0.3%

Dividend/Share (TTM)

0.82

Buy Backs (1Y)

0.66%

Diluted EPS (TTM)

6.75

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20252.9B3.0B3.0B0
20242.9B2.9B2.9B2.9B
20232.9B2.9B2.9B2.9B
20222.9B2.9B2.9B2.9B
20212.3B2.5B2.7B2.8B
20201.9B1.9B2.0B2.1B
20191.7B1.8B1.8B1.8B
20181.6B1.7B1.7B1.7B
20171.5B1.5B1.6B1.6B
20161.4B1.5B1.5B1.5B
20151.4B1.4B1.4B1.4B
20141.4B1.4B1.4B1.4B
20131.3B1.3B1.3B1.4B
20121.2B1.2B1.2B1.3B
20111.1B1.2B1.2B1.2B
20100001.1B
Get all data in R, Python etc through our Historical Stock Data APIs

About West Pharmaceutical Services Inc

WST
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. The company serves pharmaceutical, diagnostic, and medical device companies. It distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. The company was incorporated in 1923 and is headquartered in Exton, Pennsylvania.
 CEO
 WEBSITEwestpharma.com
 SECTORHealthcare
 INDUSTRYMedical Instruments & Supplies
 EMPLOYEES10700

West Pharmaceutical Services Inc Frequently Asked Questions

WST is the stock ticker symbol of West Pharmaceutical Services Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of West Pharmaceutical Services Inc is 16.97 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check WST's fair value in chart for subscribers.

The fair value guage provides a quick view whether WST is over valued or under valued. Whether West Pharmaceutical Services Inc is cheap or expensive depends on the assumptions which impact West Pharmaceutical Services Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for WST.

As of Wed Jan 28 2026, WST's PE ratio (Price to Earnings) is 34.51 and Price to Sales (PS) ratio is 5.62. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. WST PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, West Pharmaceutical Services Inc has provided 0.152 (multiply by 100 for percentage) rate of return.